CareLit · DOI-Nachweis · Klinische Neurophysiologie
No difference in efficacy between Xeomin® and Botox® in the treatment of cervical dystonia – a detailed subgroup analysis
DOI 10.1055/s-2007-1032256
Bibliografische Angaben
Nachweis in CareLit
Autor:innenH Hefter, R Benecke, G Comes
ZeitschriftKlinische Neurophysiologie
Ausgabe01/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Treatment of cervical dystonia (CD) with the highly purified Botulinum neurotoxin type A (BTX-A) free of complexing proteins (Xeomin) is mainly based on the largest controlled study of BTX-A ever performed (Benecke et al. 2005) demonstrating that Xeomin is non-inferior to Botox and that in average the efficacy of one Xeomin unit is equivalent to one Botox unit. To support this dose ratio, we re-analyse…
Zitieren
Zitierempfehlung
H Hefter, R Benecke, G Comes (2008) No difference in efficacy between Xeomin® and Botox® in the treatment of cervical dystonia – a detailed subgroup analysis. Klinische Neurophysiologie (01). https://doi.org/10.1055/s-2007-1032256
Mit CareLit weiterarbeiten